Pasithea Therapeutics Corp. (KTTA) DCF Valuation

Pasithea Therapeutics Corp. (KTTA) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Pasithea Therapeutics Corp. (KTTA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to determine the intrinsic value of Pasithea Therapeutics Corp.? Our (KTTA) DCF Calculator integrates real-world data and offers extensive customization options, enabling you to refine your forecasts and enhance your investment strategies.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .5 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 3130.37 -100 0 0 0 0 0
EBITDA .0 -4.5 -12.6 -15.3 .0 .0 .0 .0 .0
EBITDA, % 100 -29916.57 -2586.3 100 0 0 0 0 0
Depreciation .1 .0 .0 .6 .0 .0 .0 .0 .0
Depreciation, % 100 9.16 1.05 100 52.55 52.55 52.55 52.55 52.55
EBIT -.1 -4.5 -12.6 -16.0 .0 .0 .0 .0 .0
EBIT, % 100 -29925.73 -2587.35 100 0 0 0 0 0
Total Cash .2 53.0 33.1 16.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .4 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0
Account Receivables, % 100 0 0 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 0 0.000205524921 100 50 50 50 50 50
Accounts Payable .0 .4 1.5 2.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 2969.59 304.46 100 100 100 100 100 100
Capital Expenditure .0 .0 -2.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 -142.76 -439.54 100 -50 -50 -50 -50 -50
Tax Rate, % -2.93 -2.93 -2.93 -2.93 -2.93 -2.93 -2.93 -2.93 -2.93
EBITAT -.1 -4.5 -11.8 -16.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .0 -4.1 -12.9 -14.7 -2.6 .0 .0 .0 .0
WACC, % 8.23 8.23 8.23 8.23 8.23 8.23 8.23 8.23 8.23
PV UFCF
SUM PV UFCF .0 .0 .0 .0 .0 .0 .0 .0 -2.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -16
Equity Value 14
Diluted Shares Outstanding, MM 1
Equity Value Per Share 11.32

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Pasithea Therapeutics Corp.'s (KTTA) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model that adjusts to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for Pasithea Therapeutics Corp. (KTTA).
  • WACC Calculator: An integrated Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Pasithea Therapeutics Corp. (KTTA).
  • Interactive Dashboard and Charts: Visual representations provide a clear overview of essential valuation metrics for straightforward analysis.

How It Works

  • Step 1: Download the prebuilt Excel template containing Pasithea Therapeutics Corp. (KTTA) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Pasithea Therapeutics Corp.'s (KTTA) intrinsic value.
  • Step 5: Make well-informed investment choices or create reports based on the outputs.

Why Choose This Calculator for Pasithea Therapeutics Corp. (KTTA)?

  • Accurate Data: Utilizes real Pasithea financials to provide trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the effort of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Designed with an intuitive interface and clear instructions to assist all users.

Who Should Use This Product?

  • Investors: Evaluate Pasithea Therapeutics Corp.'s (KTTA) potential before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess market projections.
  • Startup Founders: Understand the valuation strategies of innovative biotech companies like Pasithea Therapeutics Corp. (KTTA).
  • Consultants: Provide expert valuation insights and reports for clients in the healthcare sector.
  • Students and Educators: Utilize current data to learn and teach valuation approaches in the biotech industry.

What the Template Contains

  • Pre-Filled Data: Contains Pasithea Therapeutics' historical financials and projections.
  • Discounted Cash Flow Model: An editable DCF valuation model featuring automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated worksheet for WACC calculations based on user-defined inputs.
  • Key Financial Ratios: Evaluate Pasithea's profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.

No products were found matching.